Research Article
Does i-T744C P2Y12 Polymorphism Modulate Clopidogrel Response among Moroccan Acute Coronary Syndromes Patients?
Table 4
Baseline characteristics of our SCA patients versus VerifyNow test results.
| | Nonresistant% | Resistant% | value |
| Age | 56.9 ± 8.48 | 62 ± 8.02 | 0.9 | Sex | | | 0.41 | Male | 58.3% | 20% | | Female | 41.7% | 80% | | SCA type | | | 0.2 | ST (+) | 36% | 60% | | ST (−) | 64% | 40% | | Familial ACD | | | 0.8 | Presence | 2.8% | 0% | | Absence | 97.2% | 100% | | Personal ACD | | | 0.3 | Presence | 41.7% | 20% | | Absence | 58.3% | 80% | | Diabetes | | | 0.6 | Presence | 40.3% | 40% | | Absence | 59.7% | 60% | | HTA | | | 0.46 | Presence | 47.2% | 60% | | Absence | 52.8% | 40% | | Dyslipidemia | | | 0.22 | Presence | 16.7% | 40% | | Absence | 83.3% | 60% | | Smoking | | | 0.6 | Presence | 40.3% | 40% | | Absence | 59.7% | 60% | | Creatinine (mg/L) | 11.6 ± 10.87 | 15 ± 4.34 | | Fibrinogen | 3.57 ± 1.06 | 5.03 ± 1.14 | | Pq | 242333 ± 102412 | 159427 ± 79609 | | IPP | | | | Used | 50.38% | 60% | | Nonused | 49.62% | 40% | |
|
|
Statistically significant.
|